00:00Pfizer stock PFE is making headlines again, but is it time to buy, sell, or wait?
00:07Pfizer, once a market darling during the vaccine boom, has seen its shares slide over the past
00:13year, dropping more than 30 as COVID-related revenues faded and investor confidence wavered.
00:19But now, Pfizer's betting big on new treatments, from cancer therapies to weight loss drugs,
00:25and a $43 billion CGEN acquisition. Wall Street? Still mixed. Some analysts say there's long-term
00:33upside. Others remain cautious due to weak near-term earnings. Is Pfizer gearing up for
00:39a comeback or facing more uncertainty? Let us know your take. Will PFE rebound or keep sinking?
Comments